Clinical Trials Logo

Mitral Regurgitation clinical trials

View clinical trials related to Mitral Regurgitation.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06191718 Active, not recruiting - Clinical trials for Mitral Regurgitation

Clinical Investigation for the Foldax Tria Mitral Valve- India

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a clinical investigation of the Foldax Tria Mitral Valve to collect evidence on the device's safety and performance.

NCT ID: NCT04464876 Active, not recruiting - Clinical trials for Mitral Regurgitation

SATURN Transcatheter Mitral Valve Replacement for Functional Mitral Regurgitation

Start date: August 19, 2020
Phase: N/A
Study type: Interventional

This study is a prospective, single-arm, multi-center feasibility clinical study of the SATURN TA System for the treatment of NYHA Class ≥ II patients with severe functional mitral regurgitation who are not suitable for surgical treatment following Heart Team assessment.

NCT ID: NCT04415138 Active, not recruiting - Surgery Clinical Trials

Evaluation of Robotic-assisted Mitral Surgery With the daVinci X Surgical System

Start date: March 10, 2020
Phase:
Study type: Observational [Patient Registry]

Robotic assistance allows performance of mitral valve operations with a truly minimally invasive and totally thoracoscopic approach, with significant advantages for patients compared to sternotomy-based surgery. Nonetheless, its diffusion has been limited by: 1) significant learning curve and technical requirements; 2) increased immediate financial costs due to dedicated equipment and materials. The aim of the present study is to perform a prospective data collection and evaluation of the in-hospital and follow-up clinical results of mitral valve repair using the last generation DaVinci X robotic platform. A cost-effectiveness analysis of this approach will be also conducted, under a global healthcare system perspective (including the overall patients' pathway starting from diagnosis of mitral valve disease until the completion of the 1st postoperative year). Since the 'competitor' surgical technique is not represented by sternotomy-based mitral surgery, but instead by minimally invasive, video-assisted mitral surgery, patients operated on using such technique will serve as controls.

NCT ID: NCT04375332 Active, not recruiting - Clinical trials for Mitral Regurgitation

Beating Heart Mitral Valve Repair With the HARPOON™ System

RESTORE
Start date: December 16, 2020
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the safety and effectiveness of the HARPOON™ System in the treatment of patients with severe degenerative mitral regurgitation (DMR).

NCT ID: NCT04259411 Active, not recruiting - Clinical trials for Mitral Regurgitation

MitraClip China PMS

Start date: December 6, 2021
Phase: N/A
Study type: Interventional

The MitraClip System is the first commercially available catheter-based option for the treatment of MR. The MitraClip System was developed as an alternate percutaneous technology which may serve as a viable therapeutic option for open-heart surgery. Treatment with the MitraClip device allows patients to undergo a less invasive procedure that can mechanistically reduce MR and allow for improved quality of life. The MitraClip procedure is performed under general anesthesia without the use of a heart-lung machine, with recovery typically lasting two to three days.

NCT ID: NCT04245956 Active, not recruiting - Clinical trials for Coronary Artery Disease

Impact of Mitral Regurgitation on Coronary Haemodynamics and Instantaneous Effect of Transcatheter Mitral Valve Repair

MitraFLOW
Start date: January 8, 2020
Phase: N/A
Study type: Interventional

In the present study, the investigators aim to use the in-vivo Transcatheter Mitral Valve Repair (TMVR) model to determine how Mitral Regurgitation (MR) affects coronary hemodynamics in patients affected with severe MR and concomittant angiographically-documented coronary artery disease. The investigators will also provide unique physiologic data on the acute effect of TMVR using the MitraClip system on coronary microcirculation in patients with severe MR.

NCT ID: NCT04177394 Active, not recruiting - Clinical trials for Mitral Regurgitation

MitraClip EXPAND G4 Study

Start date: January 17, 2020
Phase:
Study type: Observational

This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.

NCT ID: NCT03813524 Active, not recruiting - Clinical trials for Mitral Regurgitation

Cardiovalve Transfemoral Mitral Valve System

AHEAD
Start date: March 26, 2019
Phase: N/A
Study type: Interventional

This study is to evaluate the safety and technical performance of the Cardiovalve Transfemoral Mitral Valve System with its associated procedure, to minimize mitral regurgitation. Data collected in this clinical study will include 30-day safety and performance of the device and delivery system, and long-term clinical outcomes over a follow-up of 5 years.

NCT ID: NCT03661398 Active, not recruiting - Clinical trials for Mitral Regurgitation

Caisson Transcatheter Mitral Valve Replacement (TMVR)

INTERLUDE
Start date: July 20, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and performance of Transcatheter Mitral Valve Replacement (TMVR) system for the treatment of severe, symptomatic mitral regurgitation (MR).

NCT ID: NCT03600688 Active, not recruiting - Clinical trials for Mitral Regurgitation

Edwards Cardioband European Post-Market Study, MiBAND

MiBAND
Start date: June 6, 2018
Phase:
Study type: Observational

To demonstrate reduction of MR with durable performance and im-provements in functional status